Skip to content

RADX

Radiopharm Theranostics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$0.87
−2.18%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
9.71x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.79x
Price / sales
7.10x
Price / cash flow
-0.36x

Enterprise value

Enterprise value
$9.1M
EV / sales
4.75x
EV / EBITDA
-0.19x
EV / EBIT
-0.19x
Market cap
$13.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026